Medical Care

Global Respiratory Distress Syndrome Management Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Respiratory Distress Syndrome Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Distress Syndrome Management.
The Respiratory Distress Syndrome Management market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Respiratory Distress Syndrome Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Distress Syndrome Management companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Windtree Therapeutics
Pfizer
Takeda
GSK
Segment by Type
Poractant Alfa
Beractant
Calfactant
Others
Segment by Application
Very Preterm Infants
Moderate to Late Preterm Infants
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Respiratory Distress Syndrome Management company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Distress Syndrome Management Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Poractant Alfa
1.2.3 Beractant
1.2.4 Calfactant
1.2.5 Others
1.3 Market by Application
1.3.1 Global Respiratory Distress Syndrome Management Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Very Preterm Infants
1.3.3 Moderate to Late Preterm Infants
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Distress Syndrome Management Market Perspective (2020-2031)
2.2 Global Respiratory Distress Syndrome Management Growth Trends by Region
2.2.1 Global Respiratory Distress Syndrome Management Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Respiratory Distress Syndrome Management Historic Market Size by Region (2020-2025)
2.2.3 Respiratory Distress Syndrome Management Forecasted Market Size by Region (2026-2031)
2.3 Respiratory Distress Syndrome Management Market Dynamics
2.3.1 Respiratory Distress Syndrome Management Industry Trends
2.3.2 Respiratory Distress Syndrome Management Market Drivers
2.3.3 Respiratory Distress Syndrome Management Market Challenges
2.3.4 Respiratory Distress Syndrome Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Distress Syndrome Management Players by Revenue
3.1.1 Global Top Respiratory Distress Syndrome Management Players by Revenue (2020-2025)
3.1.2 Global Respiratory Distress Syndrome Management Revenue Market Share by Players (2020-2025)
3.2 Global Top Respiratory Distress Syndrome Management Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Respiratory Distress Syndrome Management Revenue
3.4 Global Respiratory Distress Syndrome Management Market Concentration Ratio
3.4.1 Global Respiratory Distress Syndrome Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Distress Syndrome Management Revenue in 2024
3.5 Global Key Players of Respiratory Distress Syndrome Management Head office and Area Served
3.6 Global Key Players of Respiratory Distress Syndrome Management, Product and Application
3.7 Global Key Players of Respiratory Distress Syndrome Management, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Distress Syndrome Management Breakdown Data by Type
4.1 Global Respiratory Distress Syndrome Management Historic Market Size by Type (2020-2025)
4.2 Global Respiratory Distress Syndrome Management Forecasted Market Size by Type (2026-2031)
5 Respiratory Distress Syndrome Management Breakdown Data by Application
5.1 Global Respiratory Distress Syndrome Management Historic Market Size by Application (2020-2025)
5.2 Global Respiratory Distress Syndrome Management Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Respiratory Distress Syndrome Management Market Size (2020-2031)
6.2 North America Respiratory Distress Syndrome Management Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Respiratory Distress Syndrome Management Market Size by Country (2020-2025)
6.4 North America Respiratory Distress Syndrome Management Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Respiratory Distress Syndrome Management Market Size (2020-2031)
7.2 Europe Respiratory Distress Syndrome Management Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Respiratory Distress Syndrome Management Market Size by Country (2020-2025)
7.4 Europe Respiratory Distress Syndrome Management Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Distress Syndrome Management Market Size (2020-2031)
8.2 Asia-Pacific Respiratory Distress Syndrome Management Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Respiratory Distress Syndrome Management Market Size by Region (2020-2025)
8.4 Asia-Pacific Respiratory Distress Syndrome Management Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Respiratory Distress Syndrome Management Market Size (2020-2031)
9.2 Latin America Respiratory Distress Syndrome Management Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Respiratory Distress Syndrome Management Market Size by Country (2020-2025)
9.4 Latin America Respiratory Distress Syndrome Management Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Distress Syndrome Management Market Size (2020-2031)
10.2 Middle East & Africa Respiratory Distress Syndrome Management Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Respiratory Distress Syndrome Management Market Size by Country (2020-2025)
10.4 Middle East & Africa Respiratory Distress Syndrome Management Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Chiesi Farmaceutici
11.1.1 Chiesi Farmaceutici Company Details
11.1.2 Chiesi Farmaceutici Business Overview
11.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Management Introduction
11.1.4 Chiesi Farmaceutici Revenue in Respiratory Distress Syndrome Management Business (2020-2025)
11.1.5 Chiesi Farmaceutici Recent Development
11.2 CR-Double Crane
11.2.1 CR-Double Crane Company Details
11.2.2 CR-Double Crane Business Overview
11.2.3 CR-Double Crane Respiratory Distress Syndrome Management Introduction
11.2.4 CR-Double Crane Revenue in Respiratory Distress Syndrome Management Business (2020-2025)
11.2.5 CR-Double Crane Recent Development
11.3 ONY Biotech
11.3.1 ONY Biotech Company Details
11.3.2 ONY Biotech Business Overview
11.3.3 ONY Biotech Respiratory Distress Syndrome Management Introduction
11.3.4 ONY Biotech Revenue in Respiratory Distress Syndrome Management Business (2020-2025)
11.3.5 ONY Biotech Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Respiratory Distress Syndrome Management Introduction
11.4.4 AbbVie Revenue in Respiratory Distress Syndrome Management Business (2020-2025)
11.4.5 AbbVie Recent Development
11.5 Yuhan Corporation
11.5.1 Yuhan Corporation Company Details
11.5.2 Yuhan Corporation Business Overview
11.5.3 Yuhan Corporation Respiratory Distress Syndrome Management Introduction
11.5.4 Yuhan Corporation Revenue in Respiratory Distress Syndrome Management Business (2020-2025)
11.5.5 Yuhan Corporation Recent Development
11.6 JW Pharmaceuticals
11.6.1 JW Pharmaceuticals Company Details
11.6.2 JW Pharmaceuticals Business Overview
11.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Management Introduction
11.6.4 JW Pharmaceuticals Revenue in Respiratory Distress Syndrome Management Business (2020-2025)
11.6.5 JW Pharmaceuticals Recent Development
11.7 Noargen
11.7.1 Noargen Company Details
11.7.2 Noargen Business Overview
11.7.3 Noargen Respiratory Distress Syndrome Management Introduction
11.7.4 Noargen Revenue in Respiratory Distress Syndrome Management Business (2020-2025)
11.7.5 Noargen Recent Development
11.8 Windtree Therapeutics
11.8.1 Windtree Therapeutics Company Details
11.8.2 Windtree Therapeutics Business Overview
11.8.3 Windtree Therapeutics Respiratory Distress Syndrome Management Introduction
11.8.4 Windtree Therapeutics Revenue in Respiratory Distress Syndrome Management Business (2020-2025)
11.8.5 Windtree Therapeutics Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Respiratory Distress Syndrome Management Introduction
11.9.4 Pfizer Revenue in Respiratory Distress Syndrome Management Business (2020-2025)
11.9.5 Pfizer Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Respiratory Distress Syndrome Management Introduction
11.10.4 Takeda Revenue in Respiratory Distress Syndrome Management Business (2020-2025)
11.10.5 Takeda Recent Development
11.11 GSK
11.11.1 GSK Company Details
11.11.2 GSK Business Overview
11.11.3 GSK Respiratory Distress Syndrome Management Introduction
11.11.4 GSK Revenue in Respiratory Distress Syndrome Management Business (2020-2025)
11.11.5 GSK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Respiratory Distress Syndrome Management Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Poractant Alfa
Table 3. Key Players of Beractant
Table 4. Key Players of Calfactant
Table 5. Key Players of Others
Table 6. Global Respiratory Distress Syndrome Management Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Respiratory Distress Syndrome Management Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Respiratory Distress Syndrome Management Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Respiratory Distress Syndrome Management Market Share by Region (2020-2025)
Table 10. Global Respiratory Distress Syndrome Management Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Respiratory Distress Syndrome Management Market Share by Region (2026-2031)
Table 12. Respiratory Distress Syndrome Management Market Trends
Table 13. Respiratory Distress Syndrome Management Market Drivers
Table 14. Respiratory Distress Syndrome Management Market Challenges
Table 15. Respiratory Distress Syndrome Management Market Restraints
Table 16. Global Respiratory Distress Syndrome Management Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Respiratory Distress Syndrome Management Market Share by Players (2020-2025)
Table 18. Global Top Respiratory Distress Syndrome Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Distress Syndrome Management as of 2024)
Table 19. Ranking of Global Top Respiratory Distress Syndrome Management Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Respiratory Distress Syndrome Management Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Respiratory Distress Syndrome Management, Headquarters and Area Served
Table 22. Global Key Players of Respiratory Distress Syndrome Management, Product and Application
Table 23. Global Key Players of Respiratory Distress Syndrome Management, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Respiratory Distress Syndrome Management Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Respiratory Distress Syndrome Management Revenue Market Share by Type (2020-2025)
Table 27. Global Respiratory Distress Syndrome Management Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Respiratory Distress Syndrome Management Revenue Market Share by Type (2026-2031)
Table 29. Global Respiratory Distress Syndrome Management Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Respiratory Distress Syndrome Management Revenue Market Share by Application (2020-2025)
Table 31. Global Respiratory Distress Syndrome Management Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Respiratory Distress Syndrome Management Revenue Market Share by Application (2026-2031)
Table 33. North America Respiratory Distress Syndrome Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Respiratory Distress Syndrome Management Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Respiratory Distress Syndrome Management Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Respiratory Distress Syndrome Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Respiratory Distress Syndrome Management Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Respiratory Distress Syndrome Management Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Respiratory Distress Syndrome Management Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Respiratory Distress Syndrome Management Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Respiratory Distress Syndrome Management Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Respiratory Distress Syndrome Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Respiratory Distress Syndrome Management Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Respiratory Distress Syndrome Management Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Respiratory Distress Syndrome Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Respiratory Distress Syndrome Management Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Respiratory Distress Syndrome Management Market Size by Country (2026-2031) & (US$ Million)
Table 48. Chiesi Farmaceutici Company Details
Table 49. Chiesi Farmaceutici Business Overview
Table 50. Chiesi Farmaceutici Respiratory Distress Syndrome Management Product
Table 51. Chiesi Farmaceutici Revenue in Respiratory Distress Syndrome Management Business (2020-2025) & (US$ Million)
Table 52. Chiesi Farmaceutici Recent Development
Table 53. CR-Double Crane Company Details
Table 54. CR-Double Crane Business Overview
Table 55. CR-Double Crane Respiratory Distress Syndrome Management Product
Table 56. CR-Double Crane Revenue in Respiratory Distress Syndrome Management Business (2020-2025) & (US$ Million)
Table 57. CR-Double Crane Recent Development
Table 58. ONY Biotech Company Details
Table 59. ONY Biotech Business Overview
Table 60. ONY Biotech Respiratory Distress Syndrome Management Product
Table 61. ONY Biotech Revenue in Respiratory Distress Syndrome Management Business (2020-2025) & (US$ Million)
Table 62. ONY Biotech Recent Development
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Respiratory Distress Syndrome Management Product
Table 66. AbbVie Revenue in Respiratory Distress Syndrome Management Business (2020-2025) & (US$ Million)
Table 67. AbbVie Recent Development
Table 68. Yuhan Corporation Company Details
Table 69. Yuhan Corporation Business Overview
Table 70. Yuhan Corporation Respiratory Distress Syndrome Management Product
Table 71. Yuhan Corporation Revenue in Respiratory Distress Syndrome Management Business (2020-2025) & (US$ Million)
Table 72. Yuhan Corporation Recent Development
Table 73. JW Pharmaceuticals Company Details
Table 74. JW Pharmaceuticals Business Overview
Table 75. JW Pharmaceuticals Respiratory Distress Syndrome Management Product
Table 76. JW Pharmaceuticals Revenue in Respiratory Distress Syndrome Management Business (2020-2025) & (US$ Million)
Table 77. JW Pharmaceuticals Recent Development
Table 78. Noargen Company Details
Table 79. Noargen Business Overview
Table 80. Noargen Respiratory Distress Syndrome Management Product
Table 81. Noargen Revenue in Respiratory Distress Syndrome Management Business (2020-2025) & (US$ Million)
Table 82. Noargen Recent Development
Table 83. Windtree Therapeutics Company Details
Table 84. Windtree Therapeutics Business Overview
Table 85. Windtree Therapeutics Respiratory Distress Syndrome Management Product
Table 86. Windtree Therapeutics Revenue in Respiratory Distress Syndrome Management Business (2020-2025) & (US$ Million)
Table 87. Windtree Therapeutics Recent Development
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Respiratory Distress Syndrome Management Product
Table 91. Pfizer Revenue in Respiratory Distress Syndrome Management Business (2020-2025) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. Takeda Company Details
Table 94. Takeda Business Overview
Table 95. Takeda Respiratory Distress Syndrome Management Product
Table 96. Takeda Revenue in Respiratory Distress Syndrome Management Business (2020-2025) & (US$ Million)
Table 97. Takeda Recent Development
Table 98. GSK Company Details
Table 99. GSK Business Overview
Table 100. GSK Respiratory Distress Syndrome Management Product
Table 101. GSK Revenue in Respiratory Distress Syndrome Management Business (2020-2025) & (US$ Million)
Table 102. GSK Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report


List of Figures
Figure 1. Respiratory Distress Syndrome Management Picture
Figure 2. Global Respiratory Distress Syndrome Management Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Respiratory Distress Syndrome Management Market Share by Type: 2024 VS 2031
Figure 4. Poractant Alfa Features
Figure 5. Beractant Features
Figure 6. Calfactant Features
Figure 7. Others Features
Figure 8. Global Respiratory Distress Syndrome Management Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Respiratory Distress Syndrome Management Market Share by Application: 2024 VS 2031
Figure 10. Very Preterm Infants Case Studies
Figure 11. Moderate to Late Preterm Infants Case Studies
Figure 12. Others Case Studies
Figure 13. Respiratory Distress Syndrome Management Report Years Considered
Figure 14. Global Respiratory Distress Syndrome Management Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Respiratory Distress Syndrome Management Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Respiratory Distress Syndrome Management Market Share by Region: 2024 VS 2031
Figure 17. Global Respiratory Distress Syndrome Management Market Share by Players in 2024
Figure 18. Global Respiratory Distress Syndrome Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Respiratory Distress Syndrome Management Revenue in 2024
Figure 20. North America Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Respiratory Distress Syndrome Management Market Share by Country (2020-2031)
Figure 22. United States Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Respiratory Distress Syndrome Management Market Share by Country (2020-2031)
Figure 26. Germany Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Ireland Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Respiratory Distress Syndrome Management Market Share by Region (2020-2031)
Figure 34. China Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia & New Zealand Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Respiratory Distress Syndrome Management Market Share by Country (2020-2031)
Figure 42. Mexico Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Respiratory Distress Syndrome Management Market Share by Country (2020-2031)
Figure 46. Israel Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Respiratory Distress Syndrome Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Chiesi Farmaceutici Revenue Growth Rate in Respiratory Distress Syndrome Management Business (2020-2025)
Figure 50. CR-Double Crane Revenue Growth Rate in Respiratory Distress Syndrome Management Business (2020-2025)
Figure 51. ONY Biotech Revenue Growth Rate in Respiratory Distress Syndrome Management Business (2020-2025)
Figure 52. AbbVie Revenue Growth Rate in Respiratory Distress Syndrome Management Business (2020-2025)
Figure 53. Yuhan Corporation Revenue Growth Rate in Respiratory Distress Syndrome Management Business (2020-2025)
Figure 54. JW Pharmaceuticals Revenue Growth Rate in Respiratory Distress Syndrome Management Business (2020-2025)
Figure 55. Noargen Revenue Growth Rate in Respiratory Distress Syndrome Management Business (2020-2025)
Figure 56. Windtree Therapeutics Revenue Growth Rate in Respiratory Distress Syndrome Management Business (2020-2025)
Figure 57. Pfizer Revenue Growth Rate in Respiratory Distress Syndrome Management Business (2020-2025)
Figure 58. Takeda Revenue Growth Rate in Respiratory Distress Syndrome Management Business (2020-2025)
Figure 59. GSK Revenue Growth Rate in Respiratory Distress Syndrome Management Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies